norm: avalo therapeuticsno LEI · no CIKMax severity: Low

Canonical registry

Avalo Therapeutics, Inc.

ent_f3f9d76a1c5cb2ad

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Avalo Therapeutics, Inc.
Normalized: avalo therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-03-29
Avalo Therapeutics' Item 1C disclosure describes its Information Security Program, governance (ISWG, Audit Committee oversight), NIST CSF-based controls, third-party MSSP monitoring, vendor risk assessments, and annual employee security awareness training including phishing simulations. The filing explicitly states the company has not identified any material cybersecurity incident to date. No breach is disclosed.